Voyageur Pharmaceuticals Ltd. (TSXV:VM)

Voyageur Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	0.44	0.27	0.17	0	0.03	0.81
Cash & Short-Term Investments	0.44	0.27	0.17	0	0.03	0.81
Cash Growth	16.78%	61.30%	7840.96%	-93.39%	-96.12%	27300.30%
Accounts Receivable	0.05	0.13	0.05	0.04	0.02	0.04
Inventory	0.12	0.05	0.07	0.01	0.01	0.01
Other Current Assets	0.03	0.15	0.07	0.04	0.09	0.02
Total Current Assets	0.64	0.6	0.36	0.09	0.16	0.89
Net Property, Plant & Equipment	0	0	0	0.01	0.01	0.03
Other Long-Term Assets	2.57	2.51	2.24	2.07	1.93	1.65
Total Assets	3.22	3.11	2.6	2.16	2.1	2.57

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Accounts Payable	2.33	1.72	1.93	0.67	0.59	0.58
Short-Term Debt	0.04	-	-	-	-	-
Current Portion of Leases	-	-	-	-	-	0.02
Other Current Liabilities	0.44	0.1	0.17	-	-	0.02
Total Current Liabilities	2.81	1.81	2.09	0.67	0.59	0.62
Long-Term Debt	-	0.04	0.04	0.04	0.03	0.03
Other Long-Term Liabilities	-	-	0.01	0.01	0.01	0.01
Total Long-Term Liabilities	-	0.04	0.05	0.05	0.04	0.04
Total Liabilities	2.81	1.85	2.15	0.73	0.63	0.66

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Common Stock	12.61	12.64	9.14	8.69	7.55	6.33
Additional Paid-in Capital	3.77	2.96	2.13	1.86	1.64	1.55
Accumulated Other Comprehensive Income	0.02	0.02	0.02	0.01	-	-
Retained Earnings	-15.99	-14.37	-10.84	-9.13	-7.73	-5.97
Shareholders' Equity	0.41	1.25	0.45	1.44	1.46	1.91
Total Liabilities & Equity	3.22	3.11	2.6	2.16	2.1	2.57

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Total Debt	0.04	0.04	0.04	0.04	0.03	0.04
Net Cash (Debt)	0.4	0.23	0.13	-0.04	0.01	0.77
Net Cash Growth	18.76%	80.82%	-	-	-99.22%	-
Net Cash Per Share	0.00	0.00	0.00	-	-	0.01
Book Value	0.41	1.25	0.45	1.44	1.46	1.91
Book Value Per Share	0.00	0.01	0.00	0.01	0.01	0.02
Tangible Book Value	0.41	1.25	0.45	1.44	1.46	1.91
Tangible Book Value Per Share	0.00	0.01	0.00	0.01	0.01	0.02

Data Source: Fiscal.ai Last updated: Jul 24, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error